Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Fourth Quarter and Year-End Financial Results and Milestones
Date:3/6/2012

al approval of CTI's marketing authorization application (the "MAA") for Pixuvri to treat adult patients with multiple relapsed or refractory aggressive non-Hodgkin B-cell lymphomas ("NHL").

"We expect that in the next few months the European Commission should adopt the CHMP's opinion for this unmet medical need and for the first time patients with multiple relapsed or refractory aggressive NHL in the E.U. will have an approved therapy to treat their disease," stated James A. Bianco, M.D., CEO of Cell Therapeutics, Inc. "We are working with consultants on developing a staffing, resource and product launch plan for Europe so upon marketing authorization and national reimbursement approvals, we can be in a position to bring Pixuvri to these patients.  With approximately 12,000 potential patients each year in the EU(1) this represents an attractive initial commercial opportunity for CTI."

"At the same time, we are moving our other late stage product candidates forward including a March meeting with the U.S. Food and Drug Administration for the phase 3 tosedostat trial in myelodysplastic syndrome ("MDS"), a precursor of acute myeloid leukemia ("AML"). Additionally a multi-center, phase 2 study with OPAXIO treating malignant brain cancer is underway based on encouraging results from the previous study in this disease. With the potential commercial launch of Pixuvri, coupled with the successful in-licensing of tosedostat, we continue to explore additional novel clinical stage compounds to expand our hematologic cancer product pipeline," Bianco added.

  • EMA's CHMP granted a positive opinion for conditional approval of CTI's MAA for Pixuvri as monotherapy for the treatment of adult patients with multiple relapsed or refractory aggressive NHL.
  • The final OPAL phase 2 results of tosedostat, which demonstrated significant response rates in elderly patients with refractory or relapsed AML, were presented in an oral session at the American Soci
    '/>"/>

  • SOURCE Cell Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2011 Financial Results on March 7
    2. Stemline Therapeutics, Inc. Names Eric K. Rowinsky, M.D. Chief Medical Officer and Head of Research and Development
    3. Cell Therapeutics, Inc. Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants
    4. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO Investor Forum
    5. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
    6. Reed V. Tuckson, M.D., Executive Vice President and Chief of Medical Affairs at UnitedHealth Group, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
    7. Intrinsic Therapeutics, Inc. Names Cary P. Hagan as President & CEO
    8. Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation
    9. Prefilled Syringes: Devices, Therapeutics, Players, Markets and Prospects
    10. Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts
    11. Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... ISELIN, N.J. , July 1, 2015 /PRNewswire/ ... medical device company focused on non-invasive continuous glucose ... of its new and completely re-designed corporate website ... and intuitive access to Echo,s technology and enhances ... The new website better communicates to prospective ...
    (Date:7/1/2015)... -- Unilife Corporation (NASDAQ: UNIS and ASX: UNS), ... systems, announced today that its debt agreement with OrbiMed ... amendment removed a covenant that required Unilife to generate ... during the six months ended June 30, 2015. There ... of the debt agreement as part of this amendment. ...
    (Date:7/1/2015)... , July 1, 2015 Qiming Venture ... to Managing Partner effective immediately. William ... has lead and participated in many Qiming healthcare deals, ... in the Chinese market. Qiming, s success in healthcare ... he has distinguished himself with his outstanding advocacy and ...
    Breaking Medicine Technology:Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3Qiming Announces the Promotion of William Hu to Managing Partner 2
    ... N.J, Dec. 6, 2011  Glowpoint, Inc. (OTCBB: GLOW), a ... , today announced that a leading global pharmaceutical services ... telepresence deployment.   This new ... pharmaceutical services provider offering clinical, commercial, consulting and capital ...
    ... Biospace Lab and the ImaBio Group (IPHC, Strasbourg) ... of a new X-ray tomographic imaging module for use with ... versatile preclinical optical imager developed for real-time in vivo ... be faster than current Micro CT systems and will provide ...
    Cached Medicine Technology:Global Pharmaceutical Services Company Turns to Glowpoint's OpenVideo™ Cloud 2Biospace Lab Collaborates With ImaBio Group to Develop a Unique X-Ray Tomographic Module for its Preclinical Imaging System 2
    (Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children ... York Community Trust. The grant will allow CCF to improve quality of care and ... CCF was formed to respond to many changes in New York’s Medicaid system. Experts ...
    (Date:7/1/2015)... ... , ... Did you know that infertility in men is more common than ... Fertility Center of Texas (AFCT) would like to talk about some natural ways to ... to be a “woman’s issue,” male fertility factors can play a role in about ...
    (Date:7/1/2015)... Florida (PRWEB) , ... July 01, 2015 , ... ... for society,” said lead author Lisa Stolzenberg, a Professor in FIU’s School of ... juveniles aged 12 to 17 years who participated in the National Survey on ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Franklin University, one of the leading educators of ... has been named Dean of the College of Health & Public Administration . ... support the vision and mission of Franklin University via curriculum planning, course scheduling, faculty ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Author Francesca Camp wasn’t always a steadfast supporter ... so too did her support of the practice; a terrible car accident years ago left ... book, “Do I Need It ? (And What if I Do?): Answers to All ...
    Breaking Medicine News(10 mins):Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Franklin University Appoints Dean of College of Health & Public Administration 2Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2
    ... , , SEBASTOPOL, Calif., ... grows, rainforest-grown yerba mate is quickly catching on ... , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090916/NE76510 ... pioneer and leader in the yerba mate beverage category, is driving yerba ...
    ... , , YONKERS, N.Y., Sept. ... for health and medical journalists. Consumer Reports ... of prescription and non-prescription drugs (including natural medicines), mental health, ... tests health and fitness products, rates the effectiveness and ...
    ... 16 /PRNewswire-Asia/ -- At the opening ceremony of China,Endoscopy ... that the,First World Conference of Endoscopy Physicians (19th General ... Endoscopy Technology Expo,will be held December 18-20, 2009, in ... Zhang Yangde, the chief editor of China Endoscopy News ...
    ... has been used to alleviate the shortage of available liver ... the living donor and recipient is crucial. Scholars of different ... formula was the most accurate for Chinese adults has remained ... to be published on August 28, 2009 in the ...
    ... gastrointestinal bleeding accounts for approximately 20% of emergency ... has been used as a first-line treatment option ... be used as a safe diagnostic and treatment ... refractory to endoscopic treatment. The incidence of rebleeding ...
    ... through all biological stages, from slight dysplasia to carcinoma. ... accurate preoperative prediction of malignancy remains one of the ... it also influences the outcome of the resection. ... 28, 2009 in the World Journal of Gastroenterology ...
    Cached Medicine News:Health News:Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 2Health News:Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 3Health News:Consumer Reports Health News 2Health News:Consumer Reports Health News 3Health News:Consumer Reports Health News 4Health News:Consumer Reports Health News 5Health News:Consumer Reports Health News 6Health News:The First World Conference of Endoscopy Physicians will be Held December 18-20, 2009, in Hong Kong 2Health News:The First World Conference of Endoscopy Physicians will be Held December 18-20, 2009, in Hong Kong 3
    Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical...
    ... device restores lordosis and ... less reaming of the ... Danek's Tapered Laparoscopic Instruments ... and reproducibly place the ...
    The Codman steerable neuroendoscope combines a high quality fiberoptic image with the flexibility and steerability required for many neuroendoscopic applications....
    3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless int...
    Medicine Products: